<DOC>
	<DOCNO>NCT02788240</DOCNO>
	<brief_summary>All consecutive ACLF ( Acute Chronic Liver failure ) patient present institute liver biliary science , irrespective etiology , survive acute phase ( i.e . 90 day onset acute chronic liver failure ) willing participate study would enrol . After perform baseline biochemical test , patient undergo transjugular liver biopsy ( TJLB ) , HVPG ( Hepatic Venous Pressure Gradient ) , Circulating CD34 cell , Bone marrow aspiration biopsy ( Histopathological immunohistochemical examination do ) .</brief_summary>
	<brief_title>To Study Influence GCSF Natural History Acute On Chronic Liver Failure After Acute Phase</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Terlipressin</mesh_term>
	<criteria>Subjects age 1865 year All patient know ACLF survive 3 month onset acute event Patients willing participate study Presence AKI ( Acute Kidney Injury ) Active sepsis ( Blood/ urine culture positive , SBP ( Spontaneous bacterial Peritonitis , LRTI ( low Respiratory Tract infection ) Sickle cell anemia HepatoCellular Carcinoma Hematological malignancy Multi organ failure Grade 3/ 4 HE ( Hepatic Encephalopathy ) HIV seropositivity Pregnancy Patients take transplant Refusal participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>